🔗 Share this article

An underground market for unapproved slimming medications is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Investigational Drug Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Viewers are urged to message these accounts directly for source information, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors promote the substance there before directing buyers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Healthcare Experts Express Worries

However, physicians and pharmacists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could lead to users administering substances of uncertain source.

Some professionals stated the popularity for retatrutide could be connected to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, advertising, and customer regulations, potentially leading to fines, legal action or imprisonment.

Service Reaction and Content Removal

Based on the social media company, the service has taken down violative material and banned related hashtags and query recommendations. The company said it was committed to keeping the service secure and allocating resources in enhancing enforcement strategies.

Online Marketplace Operations

Investigations also discovered communities with up to nine thousand members marketing retatrutide using the platform's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays channels with thousands of members, filled with photos of slimming results, positive reviews and step-by-step instructions for mixing or injecting at home.

After minutes of joining one community, a vendor posted WhatsApp details, where the majority of transactions occur. The vendor provided an instruction manual and promised shipping within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Product Details and Pricing

Inside these communities, messages display black plastic packages with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service stated it actively moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they can’t verify. Although the research behind retatrutide is sound, these online products may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her staff has previously encountered patients injured by personal administration from unverified sources. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to possibly significant medical dangers”.